Marques et al. demonstrated that serum neurofilament light chain (NfL) effectively distinguishes atypical Parkinsonism disorders (APDs) from PD, with significantly higher NfL levels in APDs, achieving 91% diagnostic accuracy [87]. This evidence concerns the gene NEFL and activated PI3K-delta syndrome.